Murae Organisor's Q1 financial report shows positive trends in profitability and earnings
Murae Organisor, a microcap pharmaceutical company, reported flat performance for the quarter ending March 2024. However, its score has improved from 0 to 4 in the last three months. The company's PAT and EPS for the quarter were the highest in the last five quarters, indicating potential for future growth.
Murae Organisor, a microcap pharmaceutical company, recently announced its financial results for the quarter ending March 2024. The company's stock has been given a 'Strong Sell' rating by MarketsMOJO.According to the financial report, Murae Organisor's performance for the quarter has remained flat. However, there has been a significant improvement in the company's score, which has increased from 0 to 4 in the last three months.
Despite the flat performance, there are some positive aspects to Murae Organisor's financials for the quarter. The company's Profit After Tax (PAT) for the quarter was the highest in the last five quarters, standing at Rs 1.17 crore. This indicates a positive trend in the near term for the company's profitability. Additionally, the company's Earnings per Share (EPS) for the quarter was also the highest in the last five quarters, at Rs 0.05. This shows that Murae Organisor has been able to create higher earnings for its shareholders.
As a microcap company in the pharmaceutical industry, Murae Organisor's financial results for the quarter may not have met expectations. However, the company's positive PAT and EPS trends suggest that it may have potential for growth in the future. Investors should keep an eye on the company's performance in the coming quarters to see if it can sustain this positive trend.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
